Correlation Between Pfizer and TARGET
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and TARGET P 7, you can compare the effects of market volatilities on Pfizer and TARGET and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of TARGET. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and TARGET.
Diversification Opportunities for Pfizer and TARGET
Very good diversification
The 3 months correlation between Pfizer and TARGET is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and TARGET P 7 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TARGET P 7 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with TARGET. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TARGET P 7 has no effect on the direction of Pfizer i.e., Pfizer and TARGET go up and down completely randomly.
Pair Corralation between Pfizer and TARGET
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the TARGET. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.95 times less risky than TARGET. The stock trades about -0.07 of its potential returns per unit of risk. The TARGET P 7 is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 11,356 in TARGET P 7 on October 10, 2024 and sell it today you would earn a total of 988.00 from holding TARGET P 7 or generate 8.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 38.71% |
Values | Daily Returns |
Pfizer Inc vs. TARGET P 7
Performance |
Timeline |
Pfizer Inc |
TARGET P 7 |
Pfizer and TARGET Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and TARGET
The main advantage of trading using opposite Pfizer and TARGET positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, TARGET can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TARGET will offset losses from the drop in TARGET's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
TARGET vs. Electrovaya Common Shares | TARGET vs. Allegion PLC | TARGET vs. flyExclusive, | TARGET vs. Fidus Investment Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |